We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+11.7%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$334B
AUM Growth
+$44B
Cap. Flow
+$10.5B
Cap. Flow %
3.13%
Top 10 Hldgs %
13.87%
Holding
10,649
New
1,223
Increased
4,779
Reduced
2,819
Closed
1,395

Sector Composition

Rank Sector Weight
1 Technology 13.13%
2 Financials 7.1%
3 Healthcare 6%
4 Consumer Discretionary 5.02%
5 Industrials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPSI
9101
Pioneer Power Solutions
PPSI
$32.3M
$7 ﹤0.01%
1
-1,641
-100% -$9.73K
RMCOW icon
9102
Royalty Management Holding Warrant
RMCOW
$1.39M
$7 ﹤0.01%
228
+128
+128% +$5
SCYX icon
9103
SCYNEXIS
SCYX
$48.1M
-407
Closed -$5.97K
SWVLW icon
9104
Swvl Holdings Corp Warrant
SWVLW
$148K
$7 ﹤0.01%
+992
New +$8
TRIB
9105
Trinity Biotech
TRIB
$7.83M
-1
Closed -$72
FNCH
9106
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$7 ﹤0.01%
2
RYM
9107
RYTHM Inc
RYM
$39.5M
0
CODA icon
9108
Coda Octopus Group
CODA
$114M
$6 ﹤0.01%
1
HEPA
9109
DELISTED
Hepion Pharmaceuticals
HEPA
0
GSMGW
9110
DELISTED
Cheer Holding, Inc. Warrant expiring 2/13/2025
GSMGW
$6 ﹤0.01%
+1,378
New +$9
ALSAR
9111
DELISTED
Alpha Star Acquisition Corp Rights
ALSAR
$6 ﹤0.01%
+106
New +$9
SBXC.WS
9112
DELISTED
SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SBXC.WS
$6 ﹤0.01%
77
-60
-44% -$7
JTAIW
9113
DELISTED
Jet.AI Inc. Warrant
JTAIW
$6 ﹤0.01%
+144
New +$5
SECO
9114
DELISTED
Secoo Holding Limited ADR
SECO
$6 ﹤0.01%
+10
New +$6
BNBX
9115
DELISTED
BNB PLUS CORP
BNBX
0
DTSTW
9116
DELISTED
Data Storage Corp Warrant
DTSTW
$5 ﹤0.01%
40
-6,533
-99% -$1.1K
GDEVW icon
9117
GDEV Inc Warrant
GDEVW
$42.5K
$5 ﹤0.01%
+75
New +$9
NVNO
9118
enVVeno Medical
NVNO
$7.08M
0
GCTS.WS
9119
GCT Semiconductor Holding Warrants
GCTS.WS
$15M
$5 ﹤0.01%
50
-565
-92% -$63
EVE.WS
9120
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
$5 ﹤0.01%
148
-9,112
-98% -$501
GRDI
9121
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
$5 ﹤0.01%
1
-23
-96% -$202
DNA.WS
9122
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$5 ﹤0.01%
+50
New +$7
SHPW
9123
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$5 ﹤0.01%
+2
New +$5
OPGN
9124
DELISTED
OpGen, Inc
OPGN
$5 ﹤0.01%
1
CPOP icon
9125
Pop Culture Group
CPOP
$4.57M
0

Similar funds

UBS Group's Q4 2023 Portfolio in Review

As of Q4 2023, UBS Group held 10,649 positions worth $334B, up 15% from $290B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $10.5B of net new capital in Q4 2023, opening 1,223 new positions and adding to 4,779 existing holdings. Its largest new stake was Veralto: 498,566 shares worth $41M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $503M trimmed.

  • UBS Group's largest Q4 2023 buy was Veralto: 498,566 shares worth $41M.
  • UBS Group added most to UBS Group in Q4 2023, an estimated $591M increase.
  • UBS Group's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $503M.
  • UBS Group fully exited Activision Blizzard in Q4 2023, selling an estimated $370M.
  • UBS Group's ten largest holdings make up 14% of its $334B portfolio in Q4 2023.
  • UBS Group opened 1,223 new positions and closed 1,395 in Q4 2023.
  • UBS Group's portfolio value rose 15% quarter-over-quarter to $334B.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.